Due tonational shortageof the nebulization solutions, theformulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products willautomatically return to their original formulary status. SeeAlbuterol/Duoneb Shortage Mitigationfor more information. (UpdatedFeb 2023)
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
olodaterol (Striverdi Respimat)
TWO 2.5 mcg/inh inhalations once Daily (Total: 5 mcg)
Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
olodaterol (Striverdi Respimat)
albuterol nebulization
Striverdi Respimat medication guide
Striverdi is classified as non-formulary, not stocked.
Reviewed: November 18, 2014 (Striverdi Respimat)
Updated: 22 November 2016 (Striverdi Respimat)